Clinical Evidence

Can Severe Hypoglycemia be Eliminated? Introducing Estimated Residual Extracellular Insulin (EREI)

Setting: Cohort of 84 community hospitals.

Objective

This retrospective analysis compares incidence of hypoglycemia with and without use of the specialized EndoTool EREI (estimated residual extracellular insulin) adjustment feature.

Setting

Cohort of 84 community hospitals.

Results

Incidence of hypoglycemia <40 mg/dL was 63% lower when the EndoTool EREI adjustment feature was enabled.
Specifically, hypoglycemia occurred at a rate of one for every 351 patient days of intravenous insulin therapy with the EREI adjustment feature versus one for every 129 patient days without the EREI adjustment feature.

Conclusions

Use of the specialized EndoTool EREI adjustment feature significantly reduces incidence of hypoglycemia without significantly impacting glycemic control.

Objective

This retrospective analysis compares incidence of hypoglycemia with and without use of the specialized EndoTool EREI (estimated residual extracellular insulin) adjustment feature.

Setting

Cohort of 84 community hospitals.

Results

Incidence of hypoglycemia <40 mg/dL was 63% lower when the EndoTool EREI adjustment feature was enabled.
Specifically, hypoglycemia occurred at a rate of one for every 351 patient days of intravenous insulin therapy with the EREI adjustment feature versus one for every 129 patient days without the EREI adjustment feature.

Conclusions

Use of the specialized EndoTool EREI adjustment feature significantly reduces incidence of hypoglycemia without significantly impacting glycemic control.

References

Authors

W. Patrick Burgess, PhD, MD; Laura Santana, RN; Laurel Fuqua, RN, MSN.

Source

Presented at Annual Diabetes Technology Meeting. Published in Journal of Diabetes Science and Technology, Volume 1, Issue 2, p373.

Year

2019

Download

Quick navigation

Objective

This retrospective analysis compares incidence of hypoglycemia with and without use of the specialized EndoTool EREI (estimated residual extracellular insulin) adjustment feature.

Setting

Cohort of 84 community hospitals.

Results

Incidence of hypoglycemia <40 mg/dL was 63% lower when the EndoTool EREI adjustment feature was enabled.
Specifically, hypoglycemia occurred at a rate of one for every 351 patient days of intravenous insulin therapy with the EREI adjustment feature versus one for every 129 patient days without the EREI adjustment feature.

Conclusions

Use of the specialized EndoTool EREI adjustment feature significantly reduces incidence of hypoglycemia without significantly impacting glycemic control.